Finished Pharmaceutical Products (FPPs) – Page 2

Finished product assay OOS during CPV annual product review: risk assessment for patient impact and field alert / recall triggers

Detection of an OOS result often begins with regular laboratory observations or during routine quality control checks. Symptoms may include:Click to read the full article.

Finished product serialization data mismatch after method transfer to a new QC lab: updates to master batch record and in-process controls to prevent recurrence

Upon transferring serialization methods to a new QC lab, several observable symptoms may indicate a problem:Click to read the full article.

Finished product transport excursion stability impact during deviation triage meeting: risk assessment for patient impact and field alert / recall triggers

Identifying the key symptoms that indicate a finished product transport excursion is the first step in any investigation. Common symptoms may include:Click to read the full article.

Finished product particulate matter OOS during line clearance and changeover: updates to master batch record and in-process controls to prevent recurrence

Symptoms indicating a potential OOS for finished product particulate matter often arise during routine observations or laboratory testing. Key signals to monitor include:Click to read the full article.

Finished product particulate matter OOS during stability pull at accelerated conditions: stability strategy adjustments and packaging risk mitigation steps

The first step in addressing an OOS related to particulate matter is recognizing the symptoms or signals that indicate a potential issue. Common observations include:Click to read the full article.

Finished product appearance defect complaints during line clearance and changeover: how to defend specification setting and outlier handling during inspection

Complaints about finished product appearance defects often serve as early warning signals indicating deeper issues in the manufacturing process. Symptoms may include:Click to read the full article.

Finished product transport excursion stability impact during EMA/MHRA inspection preparation: updates to master batch record and in-process controls to prevent recurrence

When a transport excursion occurs, certain symptoms or signals may be observed both on the production floor and within the laboratory settings. These indicators are critical in the initial identification…

Finished product particulate matter OOS during EMA/MHRA inspection preparation: how to defend specification setting and outlier handling during inspection

Identifying symptoms related to particulate matter deviations is the first step in understanding the issue at hand. Common signals in the laboratory or manufacturing environment may include:Click to read the…

Finished product fill weight / volume variability during routine batch release: how to build a deviation package that passes an inspection deep-dive

Variability in fill weight and volume can manifest through several signals during production and testing phases:Click to read the full article.

Finished product fill weight / volume variability during routine batch release: stability strategy adjustments and packaging risk mitigation steps

Understanding the initial signals that indicate fill weight or volume variability is crucial. Symptoms may manifest at different stages of the production process, and their timely identification can prevent escalated…

Finished product transport excursion stability impact during PAI / FDA inspection readiness: how to build a deviation package that passes an inspection deep-dive

Identifying symptoms of a potential transport excursion is the first step in ensuring product integrity. Symptoms may manifest in various forms, ranging from deviations recorded in environmental monitoring reports to…

Finished product out-of-spec pH during complaint trending review: how to build a deviation package that passes an inspection deep-dive

Recognizing the symptoms that accompany OOS pH results is crucial for timely intervention. Common signals include:Click to read the full article.